Recombinant Anti-CTLA4 x Anti-GLUT2 Bispecific Antibody (CrossMab) is designed to be expressed as four chains with knobs-into-holes mutations and domain crossover. After one or multi-steps purification, high-purity antibody can be obtained. This BsAb can bind two factors simultaneously. It is designed for the research of Renal cell cancer (RCC) therapy.
There are currently no customer reviews or questions for Recombinant Human Anti-CTLA4 x Anti-GLUT2 Bispecific Antibody (CrossMab) (CROSSAB-H312). Click the button below to contact us or submit your feedback about this product.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRYSERVICES
PRODUCTS
PLATFORMS